cspc

AstraZeneca signs license agreement with China’s CSPC worth up to $2bn

The agreement includes an upfront payment of $100m with the aim to strengthen the UK firm's cardiovascular portfolio.

October 09, 2024

As part of our China Awards series, FinanceAsia reveals the rationale behind the awards for Best Transaction Banks and Solutions this year.

September 25, 2019

The Chinese private equity firm takes advantage of scorching Hong Kong capital markets to divest holding in mainland pharma firm.

April 16, 2015